NCT03959800Recruiting
Molecular Basis of Pediatric Liver Cancer
Genetic and Molecular Basis of Pediatric Liver Cancer
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1600 (estimated)
- First submitted
- 15 May 2019
- Start date
- 22 Jun 2015
- Primary completion date
- 30 Jun 2030
- Lead sponsor
- University of Pittsburgh
- NCT number
- NCT03959800
What you commit to
- Study type: Observational
- Planned participants: 1600
- From 22 Jun 2015 to the primary completion date, 30 Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No prior or current treatment for a childhood liver tumor.
Other
- Non-biological parents, legal guardians, or non-biological siblings of eligible children.
Who the study is looking for
- Prior or current treatment for a childhood liver tumor, malignant or benign, at age \<21 years.
- Biological parents and siblings of eligible children.
Age in the registry: 0 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UPMC Children's Hospital of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.